Mikaela Camacho
Neurology · South Miami, FLNPI 1659050276
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,027, 3.3 times the $611 reported in 2023.
Across 89 payments — averaging $45.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$974
- AbbVie$524
- Jazz Pharmaceuticals Inc.$306
- Amgen$216
- AstraZeneca$212
- Livanova USA, Inc.$188
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,077100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 18 | $974 |
| AbbVie | 10 | $524 |
| Jazz Pharmaceuticals Inc. | 4 | $306 |
| Amgen | 4 | $216 |
| AstraZeneca(2 entities) | 6 | $212 |
| Livanova USA, Inc. | 3 | $188 |
| SK Life Science, Inc. | 3 | $177 |
| Eisai Inc. | 3 | $147 |
| Amneal Pharmaceuticals LLC | 2 | $142 |
| Johnson & Johnson | 2 | $141 |
| Teva Pharmaceuticals USA, Inc. | 2 | $133 |
| Argenx US, Inc. | 2 | $133 |
| Merz Pharmaceuticals, LLC | 1 | $105 |
| Genentech USA, Inc. | 3 | $79 |
| EMD Serono, Inc. | 3 | $70 |
| Neurocrine Biosciences, Inc. | 3 | $63 |
| Pfizer | 3 | $61 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $53 |
| Biogen | 2 | $52 |
| ANI Pharmaceuticals, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| PTC Therapeutics, Inc. | 1 | $32 |
| TG Therapeutics, Inc. | 1 | $31 |
| Sanofi | 1 | $28 |
| MDD US Operations, LLC | 1 | $25 |
| Upsher-smith Laboratories LLC | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Octapharma USA, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Aprecia Pharmaceuticals, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,077 in reported general payments places this provider in the 60th percentile of 1,434 neurology providers in Florida.
Other neurology in South Miami
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
- Tuan VuTampa$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.